James Peyer Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 22 hours ago
James Peyer has an estimated net worth of at least $37.9 million*, as of July 23, 2025. They own 5.2 million shares of SNSE stock. They have sold 0 shares of SNSE stock since 2021, for an estimated $-2.2 million.
James Peyer $SNSE SEC Form 4 Insider Trading
James Peyer has filed a total of 36 insider trades in $SNSE since 2021. Their most recent trade was a purchase of 1,203 shares, made on Mar 02, 2022. Their largest trade was a purchase of 69,000 shares, made on Dec 29, 2021. We estimate that they now own 5.2 million shares of $SNSE, worth an estimated $40.1 million.
Insider Trading at $SNSE
There have been a total of 83 insider trades reported at $SNSE since 2021, with 882,190 shares purchased and 3.5 million shares sold. The most active insider traders in $SNSE stock have been Robert Hamilton Pierce, John Celebi, and . The most recent trade was a purchase of 500 shares reported by John Celebi (President and CEO), made on Sep 11, 2023.
History of Insider Stock Trades by James Peyer
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
SNSE
|
Purchase | 1,203 | Mar 02, 2022 | March 2, 2022, 2:40 p.m. |
|
SNSE
|
Purchase | 2,458 | Mar 01, 2022 | March 1, 2022, 7:55 p.m. |
|
SNSE
|
Purchase | 42 | Feb 28, 2022 | March 1, 2022, 7:55 p.m. |
|
SNSE
|
Purchase | 2,500 | Feb 25, 2022 | Feb. 28, 2022, 5:53 p.m. |
|
SNSE
|
Purchase | 2,500 | Feb 23, 2022 | Feb. 24, 2022, 8:12 p.m. |
|
SNSE
|
Purchase | 15,000 | Feb 24, 2022 | Feb. 24, 2022, 8:12 p.m. |
|
SNSE
|
Purchase | 4,949 | Feb 17, 2022 | Feb. 22, 2022, 12:36 p.m. |
|
SNSE
|
Purchase | 15,000 | Feb 18, 2022 | Feb. 22, 2022, 12:36 p.m. |
|
SNSE
|
Purchase | 10,000 | Feb 14, 2022 | Feb. 16, 2022, 7:54 p.m. |
|
SNSE
|
Purchase | 2,551 | Feb 16, 2022 | Feb. 16, 2022, 7:54 p.m. |
|
SNSE
|
Purchase | 12,500 | Feb 11, 2022 | Feb. 14, 2022, 8:19 p.m. |
|
SNSE
|
Purchase | 5,000 | Feb 10, 2022 | Feb. 14, 2022, 8:19 p.m. |
|
SNSE
|
Purchase | 2,500 | Feb 04, 2022 | Feb. 8, 2022, 7:40 p.m. |
|
SNSE
|
Purchase | 10,000 | Feb 08, 2022 | Feb. 8, 2022, 7:40 p.m. |
|
SNSE
|
Purchase | 17,500 | Feb 03, 2022 | Feb. 8, 2022, 7:40 p.m. |
|
SNSE
|
Purchase | 8,900 | Jan 28, 2022 | Jan. 31, 2022, 12:26 p.m. |
|
SNSE
|
Purchase | 6,100 | Jan 27, 2022 | Jan. 31, 2022, 12:26 p.m. |
|
SNSE
|
Purchase | 29,900 | Jan 26, 2022 | Jan. 27, 2022, 11:31 a.m. |
|
SNSE
|
Purchase | 20,100 | Jan 25, 2022 | Jan. 27, 2022, 11:31 a.m. |
|
SNSE
|
Purchase | 24,703 | Jan 21, 2022 | Jan. 25, 2022, 10:14 a.m. |
|
SNSE
|
Purchase | 22,707 | Jan 24, 2022 | Jan. 25, 2022, 10:14 a.m. |
|
SNSE
|
Purchase | 20,000 | Jan 20, 2022 | Jan. 21, 2022, 7:20 p.m. |
|
SNSE
|
Purchase | 10,244 | Jan 19, 2022 | Jan. 21, 2022, 7:20 p.m. |
|
SNSE
|
Purchase | 10,000 | Jan 18, 2022 | Jan. 20, 2022, 10:07 a.m. |
|
SNSE
|
Purchase | 6,219 | Jan 14, 2022 | Jan. 18, 2022, 11:20 a.m. |
|
SNSE
|
Purchase | 19,953 | Jan 13, 2022 | Jan. 18, 2022, 11:20 a.m. |
|
SNSE
|
Purchase | 9,202 | Jan 12, 2022 | Jan. 13, 2022, 5:14 p.m. |
|
SNSE
|
Purchase | 10,845 | Jan 11, 2022 | Jan. 13, 2022, 5:14 p.m. |
|
SNSE
|
Purchase | 10,000 | Jan 10, 2022 | Jan. 11, 2022, 4:29 p.m. |
|
SNSE
|
Purchase | 1,127 | Dec 30, 2021 | Jan. 3, 2022, 10:40 a.m. |
|
SNSE
|
Purchase | 69,000 | Dec 29, 2021 | Dec. 30, 2021, 1:25 p.m. |
|
SNSE
|
Purchase | 11,288 | Dec 28, 2021 | Dec. 29, 2021, 1:04 p.m. |
|
SNSE
|
Purchase | 3,712 | Dec 27, 2021 | Dec. 27, 2021, 7:08 p.m. |
|
SNSE
|
Purchase | 11,000 | Dec 23, 2021 | Dec. 23, 2021, 7:55 p.m. |
|
SNSE
|
Purchase | 117 | Dec 17, 2021 | Dec. 21, 2021, 4:54 p.m. |
|
SNSE
|
Purchase | 10,925 | Dec 16, 2021 | Dec. 20, 2021, 6:18 p.m. |
$SNSE Executives and Stock Owners with Insider Trades
-
Robert Hamilton Pierce, Chief Scientific Officer
-
John Celebi, President and CEO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.